Cue Health Management
Management criteria checks 2/4
Cue Health's CEO is Clint Sever, appointed in Mar 2024, has a tenure of less than a year. total yearly compensation is $3.14M, comprised of 17.5% salary and 82.5% bonuses, including company stock and options. directly owns 2.08% of the company’s shares, worth $476.77K. The average tenure of the management team and the board of directors is 2 years and 2.6 years respectively.
Key information
Clint Sever
Chief executive officer
US$3.1m
Total compensation
| CEO salary percentage | 17.5% |
| CEO tenure | less than a year |
| CEO ownership | 2.1% |
| Management average tenure | 2yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
Mar 22
Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Jan 28We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate
Jan 06Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%
Nov 10These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat
Aug 14Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?
Jul 12Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)
May 15Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%
Mar 21We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully
Mar 12Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price
Feb 13Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08Cue Health COVID-19 at-home, test-to-treat service launches nationwide
Aug 29Cue Health Non-GAAP EPS of -$0.37 beats by $0.09, revenue of $87.7M beats by $34.8M
Aug 10Cue Health's (NASDAQ:HLTH) Solid Profits Have Weak Fundamentals
May 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$373m |
| Sep 30 2023 | n/a | n/a | -US$257m |
| Jun 30 2023 | n/a | n/a | -US$276m |
| Mar 31 2023 | n/a | n/a | -US$291m |
| Dec 31 2022 | US$3m | US$548k | -US$194m |
| Sep 30 2022 | n/a | n/a | -US$138m |
| Jun 30 2022 | n/a | n/a | -US$67m |
| Mar 31 2022 | n/a | n/a | US$34m |
| Dec 31 2021 | US$49m | US$418k | US$33m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$24m |
| Mar 31 2021 | n/a | n/a | -US$37m |
| Dec 31 2020 | US$4m | US$243k | -US$47m |
Compensation vs Market: Clint's total compensation ($USD3.14M) is above average for companies of similar size in the US market ($USD681.24K).
Compensation vs Earnings: Clint's compensation has been consistent with company performance over the past year.
CEO
Clint Sever (38 yo)
less than a year
Tenure
US$3,136,735
Compensation
Mr. Clint Sever has been Chief Executive Officer at Cue Health Inc. since March 20, 2024. He is Co-Founder of Cue Health and served as its Chief Product Officer since its inception in January 2010. Mr. Sev...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & CEO | less than a year | US$3.14m | 2.08% $ 476.8k | |
| Co-Founder & Director | no data | US$3.79m | 7.07% $ 1.6m | |
| Chief Business Officer & Director | 2.8yrs | no data | 1.27% $ 290.5k | |
| CFO, Treasurer & Principal Financial Officer | 3yrs | no data | 0.12% $ 26.6k | |
| Controller & Principal Accounting Officer | 2yrs | no data | 0.050% $ 11.5k | |
| Vice President of Investor Relations | no data | no data | no data | |
| General Counsel & Corporate Secretary | 3.2yrs | no data | 0.16% $ 37.6k | |
| Chief Communications Officer | 2yrs | no data | no data | |
| Chief Marketing Officer | 2.3yrs | no data | no data | |
| Chief Human Resources Officer | 1.8yrs | no data | no data | |
| Chief Medical Officer | 1.6yrs | no data | no data | |
| Chief Commercial Officer | 1.6yrs | no data | no data |
2.0yrs
Average Tenure
38yo
Average Age
Experienced Management: HLTH's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Director | 14.3yrs | US$3.79m | 7.07% $ 1.6m | |
| Chief Business Officer & Director | 5.9yrs | no data | 1.27% $ 290.5k | |
| Lead Independent Director | 2.6yrs | US$229.48k | 0.0040% $ 921.4 | |
| Independent Director | 2.6yrs | US$214.94k | 0.0039% $ 903.1 | |
| Director | less than a year | no data | 0.0059% $ 1.3k | |
| Independent Director | 1.5yrs | US$316.96k | no data | |
| Independent Director | 2.6yrs | US$225.94k | 0.0040% $ 921.4 | |
| Independent Director | 1.8yrs | US$412.44k | no data |
2.6yrs
Average Tenure
48yo
Average Age
Experienced Board: HLTH's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.